List of Tables
    Table 1. Drugs for Rheumatoid Arthritis CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Drugs for Rheumatoid Arthritis Market Trends
    Table 3. Drugs for Rheumatoid Arthritis Market Drivers
    Table 4. Drugs for Rheumatoid Arthritis Market Challenges
    Table 5. Drugs for Rheumatoid Arthritis Market Restraints
    Table 6. Global Drugs for Rheumatoid Arthritis Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Drugs for Rheumatoid Arthritis Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Drugs for Rheumatoid Arthritis Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Drugs for Rheumatoid Arthritis Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Drugs for Rheumatoid Arthritis Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Drugs for Rheumatoid Arthritis Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Drugs for Rheumatoid Arthritis Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Drugs for Rheumatoid Arthritis Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Drugs for Rheumatoid Arthritis Sales Share by Manufacturer, 2017-2022
    Table 15. Global Drugs for Rheumatoid Arthritis Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Drugs for Rheumatoid Arthritis Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Drugs for Rheumatoid Arthritis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Rheumatoid Arthritis as of 2021)
    Table 18. Top Players of Drugs for Rheumatoid Arthritis in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Drugs for Rheumatoid Arthritis Product Type
    Table 20. Date of International Manufacturers Enter into Drugs for Rheumatoid Arthritis Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Drugs for Rheumatoid Arthritis Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Drugs for Rheumatoid Arthritis Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Drugs for Rheumatoid Arthritis Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Drugs for Rheumatoid Arthritis Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Drugs for Rheumatoid Arthritis Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Drugs for Rheumatoid Arthritis Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Drugs for Rheumatoid Arthritis Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Drugs for Rheumatoid Arthritis Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Drugs for Rheumatoid Arthritis Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Drugs for Rheumatoid Arthritis Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Drugs for Rheumatoid Arthritis Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Drugs for Rheumatoid Arthritis Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Drugs for Rheumatoid Arthritis Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Drugs for Rheumatoid Arthritis Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Drugs for Rheumatoid Arthritis Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Drugs for Rheumatoid Arthritis Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Drugs for Rheumatoid Arthritis Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Drugs for Rheumatoid Arthritis Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Drugs for Rheumatoid Arthritis Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Drugs for Rheumatoid Arthritis Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. AbbVie Inc Corporation Information
    Table 43. AbbVie Inc Description and Business Overview
    Table 44. AbbVie Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. AbbVie Inc Drugs for Rheumatoid Arthritis Product
    Table 46. AbbVie Inc Recent Development
    Table 47. Hoffman-La Roche AG Corporation Information
    Table 48. Hoffman-La Roche AG Description and Business Overview
    Table 49. Hoffman-La Roche AG Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Hoffman-La Roche AG Product
    Table 51. Hoffman-La Roche AG Recent Development
    Table 52. Amgen Inc Corporation Information
    Table 53. Amgen Inc Description and Business Overview
    Table 54. Amgen Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Amgen Inc Product
    Table 56. Amgen Inc Recent Development
    Table 57. Pfizer Inc Corporation Information
    Table 58. Pfizer Inc Description and Business Overview
    Table 59. Pfizer Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Pfizer Inc Product
    Table 61. Pfizer Inc Recent Development
    Table 62. Bristol-Myers Squibb Co Corporation Information
    Table 63. Bristol-Myers Squibb Co Description and Business Overview
    Table 64. Bristol-Myers Squibb Co Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Bristol-Myers Squibb Co Product
    Table 66. Bristol-Myers Squibb Co Recent Development
    Table 67. Johnson & Johnson Corporation Information
    Table 68. Johnson & Johnson Description and Business Overview
    Table 69. Johnson & Johnson Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Johnson & Johnson Product
    Table 71. Johnson & Johnson Recent Development
    Table 72. UCB Biosciences Inc Corporation Information
    Table 73. UCB Biosciences Inc Description and Business Overview
    Table 74. UCB Biosciences Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. UCB Biosciences Inc Product
    Table 76. UCB Biosciences Inc Recent Development
    Table 77. Mitsubishi Tanabe Pharma Corp Corporation Information
    Table 78. Mitsubishi Tanabe Pharma Corp Description and Business Overview
    Table 79. Mitsubishi Tanabe Pharma Corp Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Mitsubishi Tanabe Pharma Corp Product
    Table 81. Mitsubishi Tanabe Pharma Corp Recent Development
    Table 82. Biogen Inc Corporation Information
    Table 83. Biogen Inc Description and Business Overview
    Table 84. Biogen Inc Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Biogen Inc Product
    Table 86. Biogen Inc Recent Development
    Table 87. Merck & Co Corporation Information
    Table 88. Merck & Co Description and Business Overview
    Table 89. Merck & Co Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Merck & Co Product
    Table 91. Merck & Co Recent Development
    Table 92. Market Segment by Product Type Corporation Information
    Table 93. Market Segment by Product Type Description and Business Overview
    Table 94. Market Segment by Product Type Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Market Segment by Product Type Product
    Table 96. Market Segment by Product Type Recent Development
    Table 97. Pharmaceuticals Corporation Information
    Table 98. Pharmaceuticals Description and Business Overview
    Table 99. Pharmaceuticals Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Pharmaceuticals Product
    Table 101. Pharmaceuticals Recent Development
    Table 102. Biopharmaceuticals Corporation Information
    Table 103. Biopharmaceuticals Description and Business Overview
    Table 104. Biopharmaceuticals Drugs for Rheumatoid Arthritis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. Biopharmaceuticals Product
    Table 106. Biopharmaceuticals Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Drugs for Rheumatoid Arthritis Customers List
    Table 110. Drugs for Rheumatoid Arthritis Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drugs for Rheumatoid Arthritis Product Picture
    Figure 2. Global Drugs for Rheumatoid Arthritis Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Drugs for Rheumatoid Arthritis Market Size 2017-2028 (US$ Million)
    Figure 4. Global Drugs for Rheumatoid Arthritis Sales 2017-2028 (K Units)
    Figure 5. United States Drugs for Rheumatoid Arthritis Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Drugs for Rheumatoid Arthritis Market Size 2017-2028 (US$ Million)
    Figure 7. United States Drugs for Rheumatoid Arthritis Sales 2017-2028 (K Units)
    Figure 8. United States Drugs for Rheumatoid Arthritis Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Drugs for Rheumatoid Arthritis Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Drugs for Rheumatoid Arthritis Report Years Considered
    Figure 11. Product Picture of Prescription Drugs for Rheumatoid Arthritis
    Figure 12. Product Picture of OTC Drugs for Rheumatoid Arthritis
    Figure 13. Global Drugs for Rheumatoid Arthritis Market Share by Type in 2022 & 2028
    Figure 14. Global Drugs for Rheumatoid Arthritis Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Drugs for Rheumatoid Arthritis Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Drugs for Rheumatoid Arthritis Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Drugs for Rheumatoid Arthritis Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Drugs for Rheumatoid Arthritis Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Drugs for Rheumatoid Arthritis Market Share by Type in 2022 & 2028
    Figure 20. United States Drugs for Rheumatoid Arthritis Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Drugs for Rheumatoid Arthritis Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Drugs for Rheumatoid Arthritis Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Drugs for Rheumatoid Arthritis Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Drugs for Rheumatoid Arthritis Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Hospital
    Figure 26. Product Picture of Clinics
    Figure 27. Product Picture of Other
    Figure 28. Global Drugs for Rheumatoid Arthritis Market Share by Application in 2022 & 2028
    Figure 29. Global Drugs for Rheumatoid Arthritis Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Drugs for Rheumatoid Arthritis Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Drugs for Rheumatoid Arthritis Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Drugs for Rheumatoid Arthritis Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Drugs for Rheumatoid Arthritis Price by Application (2017-2028) & (USD/Unit)
    Figure 34. United States Drugs for Rheumatoid Arthritis Market Share by Application in 2022 & 2028
    Figure 35. United States Drugs for Rheumatoid Arthritis Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Drugs for Rheumatoid Arthritis Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Drugs for Rheumatoid Arthritis Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Drugs for Rheumatoid Arthritis Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Drugs for Rheumatoid Arthritis Price by Application (2017-2028) & (USD/Unit)
    Figure 40. North America Drugs for Rheumatoid Arthritis Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Drugs for Rheumatoid Arthritis Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Drugs for Rheumatoid Arthritis Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Drugs for Rheumatoid Arthritis Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Drugs for Rheumatoid Arthritis Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Drugs for Rheumatoid Arthritis Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Drugs for Rheumatoid Arthritis Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Drugs for Rheumatoid Arthritis Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Drugs for Rheumatoid Arthritis Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Drugs for Rheumatoid Arthritis Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Drugs for Rheumatoid Arthritis Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Drugs for Rheumatoid Arthritis Value Chain
    Figure 74. Drugs for Rheumatoid Arthritis Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed